News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mark Wildgust: Forefront of Innovation – The Story of Developing Bispecific Antibodies
Mark Wildgust/X
Apr 27, 2025, 12:47

Mark Wildgust: Forefront of Innovation – The Story of Developing Bispecific Antibodies

Mark Wildgust, The Janssen Pharmaceutical Companies of Johnson and Johnson, shared a post on X:

“Looking forward to sharing the story of how the Johnson and Johnson Innovative Medicine team working in partnership with the medical community, Saad Z. Usmani Marivi Mateos Byoung Chul Cho, has been at the forefront of innovation in developing bispecifics in oncology.

Register to join.”

More posts featuring Johnson and Johnson Innovative Medicine. 

cancer Chul Cho Johnson and Johnson Innovative Medicine Mark Wildgust Mateos Byoung OncoDaily Oncology Saad Z. Usmani Marivi
Special Coverage
Voices
Aug 15, 2025, 21:03
Drew Moghanaki: Cautionary Lessons from Dr. Mammarappallil on Percutaneous MWA for Lung Tumors
Voices
Aug 15, 2025, 21:01
Oliver Bogler: The NIH Review Process Doesn’t Have to Be a Mystery - Learn How to Navigate Study Section
Voices
Aug 15, 2025, 20:42
Heloisa Soares: Huntsman Cancer Institute Theranostics Program is Expanding
Insight
Aug 15, 2025, 20:14
Guilherme Harada: Honored to Have Contributed to This Study
Insight
Aug 15, 2025, 19:54
Rahul Banerjee: Faster, More Accurate Detection of Multiple Myeloma Progression
Voices
Aug 15, 2025, 19:27
Michael Chuong: Exciting Developments in RT for Pancreatic Cancer
Voices
Aug 15, 2025, 16:15
Theodoros Teknos: Case Comprehensive Cancer Center Awarded $25.5M NCI Cancer Center Support Grant
Science
Aug 15, 2025, 16:10
Saheli Sadanand: Excited to Share a New Cancer Vaccine Study in Nature Medicine
Voices
Aug 15, 2025, 16:00
Amy C Moore Highlights Persistent Challenges in Lung Cancer Survival and Research
Voices
Aug 15, 2025, 15:57
David Heredia Highlighted New Research on Membrane Targets in RET+ NSCLC
Voices
Aug 15, 2025, 15:57
Stephen Liu: Proud to Co-chair The 2026 Texas Lung Cancer Conference with Dr. Tina Cascone
Voices
Aug 15, 2025, 15:57
Minhua Chu: KRAS G12D Inhibitor GFH375 Delivers Strong Responses in NSCLC